⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL974234 | 1.00 | — | — | |
| SCHEMBL656852 | 1.00 | — | — | |
| SCHEMBL13699020 | 0.74 | — | — | |
| SCHEMBL284306 | 0.71 | — | — | |
| SCHEMBL805509 | 0.71 | — | — | |
| SCHEMBL384942 | 0.71 | — | — | |
| SCHEMBL806426 | 0.69 | — | — | |
| SCHEMBL12647089 | 0.64 | — | — | |
| SCHEMBL20334036 | 0.64 | — | — | |
| SCHEMBL4381095 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11616204-B2 | Organic electroluminescence device and organometallic compound for organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-03-28 | — | — | US | disclosed |
| WO-2021260438-A1 | ANTIBODY-DRUG CONJUGATES COMPRISING ANTI-B7-H3 ANTIBODIES | INTOCELL, INC. (KR) | 2021-12-30 | — | — | WO | disclosed |
| CN-113024608-A | Organic electroluminescent device and organometallic compound for organic electroluminescent device | 三星显示有限公司 | 2021-06-25 | — | — | CN | disclosed |
| US-20210175442-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANOMETALLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-06-10 | — | — | US | disclosed |
| US-10991611-B2 | Wafer processing laminate and method for processing wafer | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-04-27 | — | — | US | disclosed |
| EP-3366674-B1 | PYRIDINE COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2020-12-23 | — | — | EP | disclosed |
| WO-2020141460-A2 | COMPOUNDS COMPRISING CLEAVABLE LINKER AND USES THEREOF | INTOCELL, INC. (KR) | 2020-07-09 | — | — | WO | disclosed |
| US-20200146634-A1 | Methods of Lag-Compensation for Analyte Measurements, and Devices Related Thereto | ABBOTT DIABETES CARE INC. (US) | 2020-05-14 | — | — | US | disclosed |
| US-10561372-B2 | Methods of lag-compensation for analyte measurements, and devices related thereto | ABBOTT DIABETES CARE INC. (US) | 2020-02-18 | — | — | US | disclosed |
| US-10472471-B2 | Masterbatch comprising colorant particles and a polyol poly(hydroxy fatty acid) ester as dispersing agent | EINAR A/S (DK) | 2019-11-12 | — | — | US | disclosed |
| EP-1696501-B1 | Electrolyte for a lithium battery and a lithium battery comprising the same | SAMSUNG SDI CO LTD (KR) | 2007-12-05 | — | — | EP | disclosed |
| US-20070270412-A1 | NOVEL PHARMACEUTICALS | PFIZER INC | 2007-11-22 | — | — | US | disclosed |
| US-20070232586-A1 | Hydrazino-Substituted Heterocyclic Nitrile Compounds and Use Thereof | OHMOTO KAZUYUKI | 2007-10-04 | — | — | US | disclosed |
| US-7262192-B2 | Substituted pyrazolo[4,3-d]pyrimidines and their use as PDE-5 inhibitors | PFIZER INC. (US) | 2007-08-28 | — | — | US | disclosed |
| US-20070197510-A1 | Nitriles and medicinal compositions containing the same as the active ingredient | ONO PHARMACEUTICAL CO., LTD. (JP) | 2007-08-23 | — | — | US | disclosed |
| WO-2007041365-B1 | 3-CYCLYL-2- (4-SULFAMO YL-PHENYL) -N-CYCLYL-PROPIONAMIDE DERIVATIVES USEFUL IN THE TREATMENT OF IMPAIRED GLUCOSE TOLERANCE AND DIABETES | NOVARTIS AG (CH) | 2007-08-16 | — | — | WO | disclosed |
| US-20070191364-A1 | AMINOPIPERIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF | SANOFI-AVENTIS (FR) | 2007-08-16 | — | — | US | disclosed |
| WO-2007041365-A2 | 3-CYCLYL-2- (4-SULFAMO YL-PHENYL) -N-CYCLYL-PROPIONAMIDE DERIVATIVES USEFUL IN THE TREATMENT OF IMPAIRED GLUCOSE TOLERANCE AND DIABETES | NOVARTIS AG (CH) | 2007-04-12 | — | — | WO | disclosed |
| EP-1651640-B1 | NICOTINAMIDE DERIVATIVES USEFUL AS PDE4 INHIBITORS | PFIZER LTD (GB) | 2007-02-14 | — | — | EP | disclosed |
| WO-2004096810-A1 | 5,7-DIAMINOPYRAZOLO`4,3-D!PYRIMIDINES USEFUL IN THE TREATMENT OF HYPERTENSION | PFIZER LIMITED (GB) | 2004-11-11 | — | — | WO | disclosed |